Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Low Grade Glioma (LGG)”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Not applicableStudy completedNCT00137488
What this trial is testing

Angiogenic Profile and Non-invasive Imaging May Predict Tumor Progression of High Risk Group Low Grade Glioma (LGG)

Who this might be right for
Glioma
AHS Cancer Control Alberta 10
Early research (Phase 1)Ended earlyNCT02240758
What this trial is testing

Confocal Laser Endomicroscopy for Brain Tumors

Who this might be right for
Low Grade Glioma (LGG), High Grade Glioma (HGG)
Hospices Civils de Lyon 10
Testing effectiveness (Phase 2)Looking for participantsNCT05503797
What this trial is testing

Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Who this might be right for
Cancer Harboring BRAF AlterationsHGGLGG+1 more
Fore Biotherapeutics 254
Testing effectiveness (Phase 2)Study completedNCT02034110
What this trial is testing

Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare Cancers

Who this might be right for
Cancer
Novartis Pharmaceuticals 206
Testing effectiveness (Phase 2)Active Not RecruitingNCT03363217
What this trial is testing

Trametinib for Pediatric Neuro-oncology Patients With Refractory Tumor and Activation of the MAPK/ERK Pathway.

Who this might be right for
Low-grade GliomaPlexiform NeurofibromaCentral Nervous System Glioma
St. Justine's Hospital 114
Large-scale testing (Phase 3)Active Not RecruitingNCT03871257
What this trial is testing

The Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma

Who this might be right for
Low Grade GliomaNeurofibromatosis Type 1Visual Pathway Glioma
National Cancer Institute (NCI) 165
Large-scale testing (Phase 3)Looking for participantsNCT03534050
What this trial is testing

Neuropsychological and Oncological Outcomes in Grade 2 or 3 Glioma Patients Undergoing Postoperative Modern Radiotherapy

Who this might be right for
Glioma of Brain
Chang Gung Memorial Hospital 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT02840409
What this trial is testing

Vinblastine +/- Bevacizumab in Children With Unresectable or Progressive Low Grade Glioma (LGG)

Who this might be right for
Low Grade Glioma
The Hospital for Sick Children 109
Not applicableEnded earlyNCT01452854
What this trial is testing

Ovarian Aging in Low Grade Glioma (LGG) Treated With Temozolomide

Who this might be right for
Low Grade Glioma
University of California, San Francisco 2
Testing effectiveness (Phase 2)Study completedNCT02684058
What this trial is testing

Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors

Who this might be right for
Diffuse AstrocytomaAnaplastic AstrocytomaAstrocytoma+19 more
Novartis Pharmaceuticals 151
Large-scale testing (Phase 3)Looking for participantsNCT04166409
What this trial is testing

The Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

Who this might be right for
Low Grade AstrocytomaLow Grade GliomaMetastatic Low Grade Astrocytoma+3 more
National Cancer Institute (NCI) 170
Very early researchLooking for participantsNCT05555550
What this trial is testing

Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG

Who this might be right for
GliomaLow-grade GliomaLow Grade Glioma of Brain+2 more
Children's Hospital of Philadelphia 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04201457
What this trial is testing

A Trial of Dabrafenib, Trametinib and Hydroxychloroquine for Patients With Recurrent LGG or HGG With a BRAF Aberration

Who this might be right for
Low Grade Glioma (LGG) of Brain With BRAF AberrationHigh Grade Glioma (HGG) of the Brain With BRAF AberrationLow Grade Glioma of Brain With Neurofibromatosis Type 1
Pediatric Brain Tumor Consortium 57
Early research (Phase 1)Study completedNCT02473380
What this trial is testing

Fluorescence Spectroscopy Guided Surgery

Who this might be right for
Low Grade Glioma (LGG)High Grade Glioma (HGG)
Hospices Civils de Lyon 11
Early research (Phase 1)Ended earlyNCT02924038
What this trial is testing

Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG)

Who this might be right for
GliomaMalignant GliomaAstrocytoma, Grade II+3 more
Nicholas Butowski 14
Not applicableLooking for participantsNCT07042620
What this trial is testing

Test a New Fluid to Improve the Quality of Images Obtained by Using Sound Waves (Ultrasound) During Surgery

Who this might be right for
Brain Tumor AdultLow Grade Glioma (LGG), High Grade Glioma (HGG)Glioblastoma
SonoClear AS 15
Not applicableLooking for participantsNCT06572475
What this trial is testing

USPIO Enhanced MR Imaging in CNS Tumours (UMIC)

Who this might be right for
Vestibular SchwannomaGlioma, Astrocytic
Northern Care Alliance NHS Foundation Trust 17
Early research (Phase 1)Looking for participantsNCT05538130
What this trial is testing

Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors

Who this might be right for
MelanomaGliomaThyroid Cancer+10 more
Pfizer 124
Testing effectiveness (Phase 2)Looking for participantsNCT02358187
What this trial is testing

A Vaccine Trial for Low Grade Gliomas

Who this might be right for
Low Grade Glioma
James Felker 25
Testing effectiveness (Phase 2)Study completedNCT00615927
What this trial is testing

Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG)

Who this might be right for
GlioblastomaGliosarcoma
Duke University 64